Code intelligence

C83.0 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code C83.0.

Elevated code riskView ICD-10 detail

Signal breakdown

2 shown · 2 total in platform

Risk: Elevated
0

Critical

0%

1

High

50%

1

Routine

50%

0

Low

0%

New this month

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L36797: MolDX: NRAS Genetic Testing — WPS

Policy LCD-L36797 · Oncology

High

Adjust billing for NRAS Genetic Testing by WPS effective 07/31/2025.

LCD L39434: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin — CGS

Policy LCD-L39434 · Hematology

Routine

Prepare for billing changes in cell transplantation services.

Audit documentation

Building an audit file that includes C83.0?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription